公开(公告)号：US12076333B2

公开(公告)日：2024-09-03

申请号：US17370703

申请日：2021-07-08

Applicant: AKER BIOMARINE HUMAN INGREDIENTS AS

Inventor： Nils Hoem ,  Finn Myhren ,  Petter-Arnt Hals ,  Armend Håti

IPC: A61K31/685 ,  A23D9/00 ,  A23J7/00 ,  A23L33/115 ,  A23L33/12 ,  A61K31/202 ,  C11B1/02 ,  C12P13/00

CPC classification number: A61K31/685 ,  A23D9/00 ,  A23J7/00 ,  A23L33/115 ,  A61K31/202 ,  C11B1/025 ,  A23L33/12 ,  A23V2002/00 ,  C12P13/001 ,  A23V2002/00 ,  A23V2250/1846 ,  A23V2250/1882

Abstract: The present invention provides marine lysophosphatidylcholine compositions for use in pharmaceuticals, nutraceuticals and functional foods, as well as methods for making marine lysophosphatidylcholine compositions.

公开(公告)号：US11986003B2

公开(公告)日：2024-05-21

申请号：US17678672

申请日：2022-02-23

Applicant: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.

Inventor： Nora Schneider ,  Jonas Hauser ,  Sean Deoni ,  Tamas Bartfai ,  Jonathan O'Regan

IPC: A23L33/00 ,  A23L33/12 ,  A23L33/15 ,  A23L33/16 ,  A24B15/38 ,  A61K9/00 ,  A61K31/14 ,  A61K31/202 ,  A61K31/519 ,  A61K31/661 ,  A61K31/70 ,  A61K31/714 ,  A61K33/00 ,  A61K33/06 ,  A61K33/26 ,  A61K33/30 ,  A61K33/42 ,  A61K45/06 ,  A61P25/28

CPC classification number: A23L33/40 ,  A23L33/12 ,  A23L33/15 ,  A23L33/16 ,  A23L33/30 ,  A24B15/38 ,  A61K9/0095 ,  A61K31/14 ,  A61K31/202 ,  A61K31/519 ,  A61K31/661 ,  A61K31/70 ,  A61K31/714 ,  A61K33/00 ,  A61K33/06 ,  A61K33/26 ,  A61K33/30 ,  A61K33/42 ,  A61K45/06 ,  A61P25/28 ,  A23V2002/00 ,  A23V2200/322 ,  A23V2250/1564 ,  A23V2250/1578 ,  A23V2250/1588 ,  A23V2250/1592 ,  A23V2250/161 ,  A23V2250/1618 ,  A23V2250/1642 ,  A23V2250/1846 ,  A23V2250/185 ,  A23V2250/1852 ,  A23V2250/1862 ,  A23V2250/1886 ,  A23V2250/5424 ,  A23V2250/7056 ,  A23V2250/706 ,  A61K33/26 ,  A61K2300/00 ,  A61K33/30 ,  A61K2300/00 ,  A61K33/34 ,  A61K2300/00 ,  A61K33/06 ,  A61K2300/00 ,  A61K33/42 ,  A61K2300/00 ,  A61K31/714 ,  A61K2300/00 ,  A61K31/519 ,  A61K2300/00 ,  A61K31/202 ,  A61K2300/00 ,  A61K31/685 ,  A61K2300/00 ,  A61K31/688 ,  A61K2300/00 ,  A61K31/133 ,  A61K2300/00 ,  A61K31/20 ,  A61K2300/00 ,  A24B15/38 ,  A23V2002/00 ,  A23V2200/322 ,  A23V2250/1578 ,  A23V2250/1588 ,  A23V2250/1592 ,  A23V2250/16 ,  A23V2250/161 ,  A23V2250/1612 ,  A23V2250/1614 ,  A23V2250/1618 ,  A23V2250/1642 ,  A23V2250/1846 ,  A23V2250/1848 ,  A23V2250/185 ,  A23V2250/1852 ,  A23V2250/1862 ,  A23V2250/1868 ,  A23V2250/304 ,  A23V2250/54242 ,  A23V2250/7056 ,  A23V2002/00 ,  A23V2200/322 ,  A23V2250/1592 ,  A23V2002/00 ,  A23V2200/322 ,  A23V2250/1642 ,  A23V2002/00 ,  A23V2200/322 ,  A23V2250/1618 ,  A23V2002/00 ,  A23V2200/322 ,  A23V2250/1578 ,  A23V2002/00 ,  A23V2200/322 ,  A23V2250/1588 ,  A23V2002/00 ,  A23V2200/322 ,  A23V2250/161

Abstract: A synthetic nutritional composition comprising a phospholipid and/or a metabolic precursor and/or metabolite thereof for use to promote, support or optimise de novo myelination, in particular the de novo myelination trajectory, and/or brain structure, and/or brain connectivity, and/or intellectual potential and/or cognitive potential, and/or learning potential and/or cognitive functioning in a subject, in particular a formula fed subject.

公开(公告)号：US20170319608A1

公开(公告)日：2017-11-09

申请号：US15662212

申请日：2017-07-27

Applicant: Allergy Research Group, LLC

Inventor： Robert A. Settineri

IPC: A61K31/702 ,  A61K31/661 ,  A61K9/00

CPC classification number: A61K31/702 ,  A23D9/013 ,  A23L29/10 ,  A23L29/244 ,  A23L33/105 ,  A23L33/115 ,  A23L33/12 ,  A23V2002/00 ,  A61K9/0056 ,  A61K9/006 ,  A61K31/05 ,  A61K31/122 ,  A61K31/16 ,  A61K31/375 ,  A61K31/385 ,  A61K31/522 ,  A61K31/593 ,  A61K31/66 ,  A61K31/661 ,  A61K31/683 ,  A61K31/685 ,  A61K31/7028 ,  A61K31/716 ,  A61K31/733 ,  A61K33/22 ,  A61K38/28 ,  A61K38/44 ,  A61K38/446 ,  A61K45/06 ,  A61K47/12 ,  A61K47/24 ,  A61K47/26 ,  A61P21/00 ,  A61P39/06 ,  C12Y111/01006 ,  C12Y115/01001 ,  A61K2300/00 ,  A23V2200/302 ,  A23V2200/316 ,  A23V2200/33 ,  A23V2250/184 ,  A23V2200/30 ,  A23V2250/1844 ,  A23V2250/1846 ,  A23V2250/1848 ,  A23V2250/185 ,  A23V2250/1852 ,  A23V2250/314 ,  A23V2250/5062 ,  A23V2250/7106 ,  A23V2250/714 ,  A23V2250/026 ,  A23V2250/708 ,  A23V2250/21

Abstract: Composition, preferably, in the form of capsules or chewable wafers in quantities suitable for relieving the symptoms of fibromyalgia comprise formulations of phospholipids, specifically identified concentrations of phosphatidylglycerol, phosphatidic acid, phosphatidylethanolamine, phosphatidylcholine, glycolipids and phosphatidylserine along with inulin and other desirable active ingredients are described.

公开(公告)号：US20170304247A1

公开(公告)日：2017-10-26

申请号：US15493148

申请日：2017-04-21

Applicant: Qualitas Health, Ltd.

Inventor： Brian J. WAIBEL ,  Hans SCHONEMANN ,  Val KRUKONIS ,  Michael KAGAN

IPC: A61K31/202 ,  C07H15/06 ,  C11B3/00 ,  C12P7/64

CPC classification number: A61K31/202 ,  A23L33/12 ,  A23V2002/00 ,  C07H15/06 ,  C11B3/006 ,  C12P7/6427 ,  A23V2250/1846 ,  A23V2250/185 ,  A23V2250/187 ,  A23V2250/2136

Abstract: Provided herein are compositions comprising eicosapentaenoic acid (EPA) and polar lipids (e.g., glycolipids and phospholipids), and which do not contain any docosahexaenoic acid (DHA) or esterified fatty acids.

公开(公告)号：US20160309769A1

公开(公告)日：2016-10-27

申请号：US15104032

申请日：2014-09-01

Applicant: NESTEC S.A.

Inventor： Carlos Antonio De Castro ,  Frederic Destaillats ,  Francesca Giuffrida ,  Sagar Thakkar ,  Rajjat Mukherjee

IPC: A23L33/00 ,  A23L33/12

CPC classification number: A23L33/40 ,  A23L33/12 ,  A23V2002/00 ,  A23V2200/322 ,  A23V2250/1846 ,  A23V2250/1848 ,  A23V2250/185 ,  A23V2250/1852 ,  A23V2250/1872 ,  A23V2250/1874

Abstract: The invention concerns synthetic nutritional formulations, particularly milk based compositions, for infants and children. The compositions are especially adapted to the gender of the child. The invention further relates to administration of these compositions for promoting the healthy establishment of cognitive function in infant boys and girls or in young boys and girls.

Abstract translation: 本发明涉及用于婴儿和儿童的合成营养制剂，特别是基于乳的组合物。 这些成分特别适合于孩子的性别。 本发明进一步涉及这些组合物的施用，用于促进婴儿男孩和女孩或年轻男孩和女孩健康建立认知功能。

公开(公告)号：US09084804B2

公开(公告)日：2015-07-21

申请号：US13977162

申请日：2011-08-11

Applicant: Martine Groenendijk ,  Patrick Joseph Gerardus Hendrikus Kamphuis ,  Mattheus Cornelis De Wilde ,  Robert Johan Joseph Hageman

Inventor： Martine Groenendijk ,  Patrick Joseph Gerardus Hendrikus Kamphuis ,  Mattheus Cornelis De Wilde ,  Robert Johan Joseph Hageman

IPC: A61K31/70 ,  A01N43/04 ,  A61K31/675 ,  A23L1/29 ,  A23L1/30 ,  A23L1/302 ,  A61K31/14 ,  A61K31/202 ,  A61K31/355 ,  A61K31/375 ,  A61K31/4415 ,  A61K31/519 ,  A61K31/683 ,  A61K31/685 ,  A61K31/7072 ,  A61K31/714 ,  A61K33/04 ,  A61K45/06 ,  A61K31/20 ,  A61K31/661 ,  A61K31/7056

CPC classification number: A61K31/675 ,  A23L33/12 ,  A23L33/13 ,  A23L33/15 ,  A23L33/40 ,  A23V2002/00 ,  A61K31/14 ,  A61K31/20 ,  A61K31/202 ,  A61K31/355 ,  A61K31/375 ,  A61K31/4415 ,  A61K31/519 ,  A61K31/661 ,  A61K31/683 ,  A61K31/685 ,  A61K31/70 ,  A61K31/7056 ,  A61K31/7068 ,  A61K31/7072 ,  A61K31/714 ,  A61K33/04 ,  A61K45/06 ,  C07H19/052 ,  C07H19/06 ,  A61K2300/00 ,  A23V2200/316 ,  A23V2200/322 ,  A23V2250/1882 ,  A23V2250/304 ,  A23V2250/704 ,  A23V2250/156 ,  A23V2250/1626 ,  A23V2250/1844 ,  A23V2250/1846 ,  A23V2250/1848 ,  A23V2250/185 ,  A23V2250/1852 ,  A23V2250/1868 ,  A23V2250/187 ,  A23V2250/5424 ,  A23V2250/7052 ,  A23V2250/7058 ,  A23V2250/706 ,  A23V2250/308

Abstract: Non-medical use of at least two components selected from the group of: (i) nucleoside equivalents, (ii) n-3 polyunsaturated fatty acids selected from the group of DHA, DPA and EPA, (iii) vitamins B, (iv) phospholipids, (v) antioxidants and (vi) cholines—with the proviso that at least one (i) nucleoside or at least one (iii) vitamin B is present—for increasing or maintaining the body weight, for improving the ability to perform an activity of daily living of a mammal, for maintaining the ability to perform an activity of daily living of a mammal, or for reducing a deterioration in the ability to perform an activity of daily living of a mammal.

Abstract translation: 至少两种选自下组的组分的非医疗用途：（i）核苷当量，（ii）选自DHA，DPA和EPA的n-3多不饱和脂肪酸，（iii）维生素B，（iv） 磷脂，（v）抗氧化剂和（vi）胆碱 - 条件是存在至少一种（i）核苷或至少一种（iii）维生素B），用于增加或维持体重，以提高执行 哺乳动物的日常生活活动，维持哺乳动物日常生活活动的能力，或降低进行哺乳动物日常生活活动能力的劣化。

公开(公告)号：US08920822B2

公开(公告)日：2014-12-30

申请号：US12947891

申请日：2010-11-17

Applicant: Ken Kato ,  Noriko Ueda ,  Susumu Miura ,  Toshimitsu Yoshioka

Inventor： Ken Kato ,  Noriko Ueda ,  Susumu Miura ,  Toshimitsu Yoshioka

IPC: A61K8/02 ,  A61Q19/08 ,  A23J7/00 ,  A23K1/16 ,  A23L1/30 ,  A61K8/68 ,  A61K31/688 ,  A61Q19/00

CPC classification number: A61Q19/08 ,  A23J7/00 ,  A23K20/158 ,  A23L33/10 ,  A23L33/115 ,  A23V2002/00 ,  A61K8/68 ,  A61K31/688 ,  A61K2800/92 ,  A61Q19/00 ,  A23V2250/1846 ,  A23V2200/318

Abstract: A skin beautifier contains sphingomyelin, which is a phospholipid, as an effective ingredient. In addition, skin-beautifying food or feed contains sphingomyelin as an effective ingredient. The present invention provides a skin beautifier and skin-beautifying food or feed supplying effects on beauty, such as skin-moisturizing and protecting effects, skin-roughness-preventing and improving effects, and a wrinkle-preventing effect, by oral ingestion thereof.

Abstract translation: 皮肤美容师含有作为有效成分的磷脂磷角蛋白。 另外，皮肤美化食品或饲料含有鞘磷脂作为有效成分。 本发明提供一种通过口服摄取，提供美容效果，例如皮肤保湿和保护效果，皮肤粗糙度防止和改善效果以及防皱效果的皮肤美容和美容美容食品。

公开(公告)号：US20130157978A1

公开(公告)日：2013-06-20

申请号：US13767730

申请日：2013-02-14

Applicant: N.V. Nutricia

Inventor： Amanda Johanne Kiliaan ,  Robert Johan Joseph Hageman

IPC: A61K31/685 ,  A61K31/4415 ,  A61K31/202 ,  A61K31/14 ,  A61K31/355 ,  A61K31/683 ,  A61K31/205 ,  A61K31/519 ,  A61K31/194

CPC classification number: A61K31/685 ,  A23L33/105 ,  A23L33/115 ,  A23L33/15 ,  A23L33/16 ,  A23V2002/00 ,  A61K31/14 ,  A61K31/194 ,  A61K31/20 ,  A61K31/202 ,  A61K31/205 ,  A61K31/355 ,  A61K31/4415 ,  A61K31/519 ,  A61K31/683 ,  A61K33/30 ,  A61K33/34 ,  A61K36/16 ,  A61K45/06 ,  A61K2300/00 ,  A23V2250/1842 ,  A23V2250/7052 ,  A23V2250/706 ,  A23V2250/161 ,  A23V2250/1642 ,  A23V2250/032 ,  A23V2250/1846 ,  A23V2250/1852 ,  A23V2250/1848 ,  A23V2250/156 ,  A23V2250/5114 ,  A23V2250/704 ,  A23V2250/716

Abstract: The present invention relates to a preparation suitable for the prevention and/or treatment of vascular disorders, comprising the following fractions: fraction a) consisting of long chain polyunsaturated fatty acids; fraction b) consisting of phospholipids, which fraction contains at least two different phospholipids selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine. fraction c) consisting of compounds which are a factor in methionine metabolism, which fraction contains at least one member selected from the group consisting of folic acid, vitamin B12, vitamin B6, magnesium and zinc.

Abstract translation: 本发明涉及适用于预防和/或治疗血管疾病的制剂，其包含以下级分：级分a）由长链多不饱和脂肪酸组成; 组分b）由磷脂组成，该级分含有至少两种选自磷脂酰丝氨酸，磷脂酰肌醇，磷脂酰胆碱和磷脂酰乙醇胺的不同磷脂。 组分c）由作为甲硫氨酸代谢因子的化合物组成，该级分含有选自叶酸，维生素B12，维生素B6，镁和锌中的至少一种。

公开(公告)号：US20120277196A1

公开(公告)日：2012-11-01

申请号：US13545830

申请日：2012-07-10

Applicant: Fotini Sampalis

Inventor： Fotini Sampalis

IPC: A61K31/683 ,  A61P9/12 ,  A61P9/00 ,  A61P3/06

CPC classification number: A61K31/661 ,  A23J7/00 ,  A23K20/158 ,  A23L33/115 ,  A23L33/30 ,  A23V2002/00 ,  A61K8/553 ,  A61K9/0053 ,  A61K9/48 ,  A61K31/122 ,  A61K31/353 ,  A61K31/6615 ,  A61K31/683 ,  A61K31/685 ,  A61K35/612 ,  A61K2800/522 ,  A61Q19/00 ,  C07D407/14 ,  C07F9/10 ,  C07F9/117 ,  C11B1/10 ,  Y10S514/824 ,  A23V2250/1846 ,  A23V2250/1852 ,  A23V2250/1848 ,  A23V2250/185 ,  A23V2250/1868 ,  A23V2250/187 ,  A23V2250/70

Abstract: A phospholipid extract from a marine or aquatic biomass possesses therapeutic properties. The phospholipid extract comprises a variety of phospholipids, fatty acid, metals and a novel flavonoid.

Abstract translation: 来自海洋或水生生物的磷脂提取物具有治疗性质。 磷脂提取物包含多种磷脂，脂肪酸，金属和新颖的类黄酮。

公开(公告)号：US20120065172A1

公开(公告)日：2012-03-15

申请号：US13280182

申请日：2011-10-24

Applicant: Fotini SAMPALIS

Inventor： Fotini SAMPALIS

IPC: A61K31/661 ,  A61P25/16 ,  A61P25/28 ,  A61P25/00

CPC classification number: A61K31/661 ,  A23J7/00 ,  A23K20/158 ,  A23L33/115 ,  A23L33/30 ,  A23V2002/00 ,  A61K8/553 ,  A61K9/0053 ,  A61K9/48 ,  A61K31/122 ,  A61K31/353 ,  A61K31/6615 ,  A61K31/683 ,  A61K31/685 ,  A61K35/612 ,  A61K2800/522 ,  A61Q19/00 ,  C07D407/14 ,  C07F9/10 ,  C07F9/117 ,  C11B1/10 ,  Y10S514/824 ,  A23V2250/1846 ,  A23V2250/1852 ,  A23V2250/1848 ,  A23V2250/185 ,  A23V2250/1868 ,  A23V2250/187 ,  A23V2250/70

Abstract: A phospholipid extract from a marine or aquatic biomass possesses therapeutic properties. The phospholipid extract comprises a variety of phospholipids, fatty acid, metals and a novel flavonoid.